This track will explore the latest findings in diabetes mellitus research, focusing on the underlying mechanisms of the disease. Emphasis will be placed on novel therapeutic targets and innovative treatment strategies.

This session will address the complications associated with Type 1 and Type 2 diabetes, including cardiovascular, renal, and neuropathic issues. Discussions will also cover effective management strategies to mitigate these complications.

This track will focus on the unique challenges faced in the diagnosis and management of pediatric diabetes. It will highlight current treatment protocols and emerging therapies tailored for children.

This session will delve into the complexities of gestational diabetes, emphasizing the importance of early detection and management. Participants will discuss evidence-based care strategies to improve maternal and fetal outcomes.

This track will examine the role of dietary management and physical activity in preventing diabetes. Evidence-based interventions and lifestyle modification strategies will be discussed to promote health and well-being.

This session will focus on the latest clinical diagnostic approaches for diabetes, including laboratory tests and screening methods. Participants will explore how early diagnosis can lead to better management outcomes.

This track will showcase advanced technologies that are transforming diabetes treatment, including continuous glucose monitoring and insulin delivery systems. The potential of digital health solutions in diabetes management will also be explored.

This session will highlight recent advancements in drug discovery and the identification of biomarkers for diabetes treatment. Discussions will focus on the implications of these discoveries for clinical practice.

This track will explore the application of computational methods in diabetes research, including data analytics and modeling. Participants will discuss how these approaches can enhance understanding and management of diabetes.

This session will address the regulatory landscape and economic factors influencing diabetes research and treatment. Discussions will focus on the implications for policy and funding in the field of diabetes.

This track will emphasize patient-oriented case management discussions in endocrinology, particularly focusing on diabetes care. Participants will share best practices and strategies for enhancing patient engagement and outcomes.